DWM
GSK icon

Doyle Wealth Management’s GSK GSK Stock Holding History

Doyle Wealth Management’s Portfolio GSK Stock Details GSK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q3 		– Sell
-1,920
Closed -$96K – 407
2019
Q2 		$96K Buy
+1,920
New +$96.3K 0.01% 268
2019
Q1 		– Sell
-1,998
Closed -$95K – 391
2018
Q4 		$95K Buy
+1,998
New +$98.4K 0.02% 263
2018
Q1 		– Sell
-4,977
Closed -$221K – 177
2017
Q4 		$221K Buy
+4,977
New +$230K 0.04% 157

Other funds holding GSK

Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
BCIM
Black Creek Investment Management Toronto, Ontario, Canada $1.86B AUM 15.33% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Hotchkis & Wiley Capital Management
Hotchkis & Wiley Capital Management Los Angeles, California $32.4B AUM 17.21% 1-Year Est. Return

Doyle Wealth Management's GSK Position: Q3 2019 in Review

Doyle Wealth Management sold out of GSK (GSK) in Q3 2019, closing a stake of 1,920 shares — an estimated $96K sold.

Doyle Wealth Management first reported a position in GSK in Q4 2017 and held it in 3 quarters. The position peaked at $221K in Q4 2017. 805 funds tracked by Wall St. Rank hold GSK as of Q3 2019.

  • Doyle Wealth Management reported no remaining GSK position as of Q3 2019 after selling out during the quarter.
  • Doyle Wealth Management sold 1,920 GSK shares in Q3 2019, an estimated $96K.
  • Doyle Wealth Management first reported a position in GSK in Q4 2017 and held it in 3 quarters.
  • Doyle Wealth Management's GSK position peaked at $221K in Q4 2017.
  • 805 funds tracked by Wall St. Rank held GSK as of Q3 2019.

Based on Doyle Wealth Management's 13F filing for Q3 2019, filed 5 Nov 2019.